Eyal Baror active positions
| Companies | Position | Start | End |
|---|---|---|---|
Neuronix Ltd.
 Neuronix Ltd. Medical SpecialtiesHealth Technology Neuronix Ltd. engages in the development and manufacture of therapy investigational devices for treatment of alzheimer’s disease. The company was founded by Jose Rabay and Jonathan Bentowitz in 2008 and is headquartered in Yokneam, Israel. | Chief Executive Officer | - | - |
| President | - | - | |
Innovalve Bio Medical Ltd.
 Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Chief Executive Officer | 2019-12-31 | - |
Career history of Eyal Baror
Statistics
International
| Israel | 3 |
Operational
| Chief Executive Officer | 2 |
| President | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Neuronix Ltd.
Neuronix Ltd. Medical SpecialtiesHealth Technology Neuronix Ltd. engages in the development and manufacture of therapy investigational devices for treatment of alzheimer’s disease. The company was founded by Jose Rabay and Jonathan Bentowitz in 2008 and is headquartered in Yokneam, Israel. | Health Technology |
Innovalve Bio Medical Ltd.
Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Eyal Baror
- Experience
